Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2024-11-25
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Differences in Access to Emergency Paediatric Intensive Care and Care During Transport
NCT03520192
Regionalized Pediatric Emergency Care in Rural Pennsylvania
NCT01775033
Performance for French Pediatric Intensive Care Units
NCT05491018
Resuscitation Registry in CHD
NCT05373498
Evaluation Of The Degree Of Kidney Injury in Children With Hypovolemic Shock
NCT06612073
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A nationwide registry for pediatric intensive care transports in Germany was initiated to describe and analyze the need for and current practice of these specialized transports.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Critically ill children undergoing interhospital pediatric intensive care transport
All critically ill children undergoing interhospital pediatric intensive care transport, aged at least 27 days and with a corrected gestational age of over 41 weeks, are eligible for inclusion. The upper age limit for enrolment is 18 years. Critical care transports are defined as transports that meet at least one of the following criteria: I) The transport was performed by a dedicated critical care transport team using an intensive care ambulance (Type C vehicle) or an air ambulance. II) The transport was accompanied by a specialist in intensive care or emergency medicine. III) The in-hospital destination of the transport is a critical care area, such as an intensive care unit, a trauma room, a resuscitation area, an operating theatre, an emergency imaging procedure or an emergency intervention.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Maximum age of 17 years AND
* Interhospital transport AND
* Critical care transport by a dedicated critical care transport team using an intensive care ambulance (Type C vehicle) or an air ambulance OR
* The transport was accompanied by a specialist in intensive care or emergency medicine. OR
* The in-hospital destination of the transport is a critical care area, such as an intensive care unit, a trauma room, a resuscitation area, an operating theatre, an emergency imaging procedure or an emergency intervention.
27 Days
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin
OTHER
Philipps University Marburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. med. Nadine Mand
Head of Neonatology and Pediatric Intensive Care, Department of Pediatrics, Marburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Dresden
Dresden, , Germany
Philipps University of Marburg
Marburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REG-EK-270072024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.